BMS-817399 is under investigation in clinical trial NCT01404585 (Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.